Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3181 AL 3195

The role of IL-15 in central nervous system disorders

Rentzos M, Rombos A.

Acta Neurol Scand. 2012 Feb;125(2):77-82. doi: 10.1111/j.1600-0404.2011.01524.x. Epub 2011 May 26.

Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond

Perier C, Bové J, Vila M.

Antioxid Redox Signal. 2012 May 1;16(9):883-95. doi: 10.1089/ars.2011.4074. Epub 2011 Jul 18.

The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?

Chen JJ, Wilkinson JR.

J Clin Pharmacol. 2012 May;52(5):620-8. doi: 10.1177/0091270011406279. Epub 2011 May 31.

Hypothyroidism in the elderly: diagnostic pitfalls illustrated by a case report

Maselli M, Inelmen EM, Giantin V, Manzato E.

Arch Gerontol Geriatr. 2012 Jul-Aug;55(1):82-4. doi: 10.1016/j.archger.2011.05.003. Epub 2011 Jun 2.

MicroRNAs in brain development and degeneration

Enciu AM, Popescu BO, Gheorghisan-Galateanu A.

Mol Biol Rep. 2012 Mar;39(3):2243-52. doi: 10.1007/s11033-011-0973-1. Epub 2011 Jun 5.

Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation

Elia AE, Dollenz C, Soliveri P, Albanese A.

Eur J Neurol. 2012 Jan;19(1):76-83. doi: 10.1111/j.1468-1331.2011.03437.x. Epub 2011 Jun 4.

Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke

Rodrigues MC, Voltarelli J, Sanberg PR, Allickson JG, Kuzmin-Nichols N, Garbuzova-Davis S, Borlongan CV.

Neurosci Biobehav Rev. 2012 Jan;36(1):177-90. doi: 10.1016/j.neubiorev.2011.05.010. Epub 2011 May 27.

Mitochondrial dynamics and Parkinson's disease: focus on parkin

Lim KL, Ng XH, Grace LG, Yao TP.

Antioxid Redox Signal. 2012 May 1;16(9):935-49. doi: 10.1089/ars.2011.4105. Epub 2011 Jul 22.

Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke

Iwamoto J, Takeda T, Matsumoto H.

Acta Neurol Scand. 2012 Apr;125(4):279-84. doi: 10.1111/j.1600-0404.2011.01555.x. Epub 2011 Jun 18.

Glucose metabolism in small subcortical structures in Parkinson's disease

Borghammer P, Hansen SB, Eggers C, Chakravarty M, Vang K, Aanerud J, Hilker R, Heiss WD, Rodell A, Munk OL, Keator D, Gjedde A.

Acta Neurol Scand. 2012 May;125(5):303-10. doi: 10.1111/j.1600-0404.2011.01556.x. Epub 2011 Jun 21.

"Preclinical" MSA in definite Creutzfeldt-Jakob disease

Rodriguez-Diehl R, Rey MJ, Gironell A, Martinez-Saez E, Ferrer I, Sánchez-Valle R, Jagüe J, Nos C, Gelpi E.

Neuropathology. 2012 Apr;32(2):158-63. doi: 10.1111/j.1440-1789.2011.01232.x. Epub 2011 Jun 21.

Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease

Ray Chaudhuri K, Martinez-Martin P, Rolfe KA, Cooper J, Rockett CB, Giorgi L, Ondo WG.

Eur J Neurol. 2012 Jan;19(1):105-13. doi: 10.1111/j.1468-1331.2011.03442.x. Epub 2011 Jun 23.

Computed tomography of a coronary sinus diverticulum associated with Wolff-Parkinson-White syndrome

Morin DP, Parker H, Khatib S, Dinshaw H.

Heart Rhythm. 2012 Aug;9(8):1338-9. doi: 10.1016/j.hrthm.2011.05.004. Epub 2011 May 10.

Clinical heterogeneity in Parkinson's disease revisited: a latent profile analysis

Flensborg Damholdt M, Shevlin M, Borghammer P, Larsen L, Ostergaard K.

Acta Neurol Scand. 2012 May;125(5):311-8. doi: 10.1111/j.1600-0404.2011.01561.x. Epub 2011 Jun 28.

Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease

Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, Labandeira-Garcia JL.

Age (Dordr). 2012 Aug;34(4):863-80. doi: 10.1007/s11357-011-9284-7. Epub 2011 Jun 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias